Skip to content

The latest news from the UW

November 5, 2001

Local researchers join in national effort to study health impact of toxic substances

The Fred Hutchinson Cancer Research Center, in collaboration with the University of Washington, has been selected to participate in a federally funded, $37 million research consortium to study how individual genetic makeup affects one’s response to various environmental agents, from asbestos to tobacco smoke. Such research will help answer puzzling questions such as why some people who have never smoked a cigarette develop lung cancer, while others who have smoked heavily for years never show signs of the disease.

Urban Horticulture to brief public Nov. 19 on concepts, design for rebuilding

Designers with the architectural firm Miller Hull Partnership of Seattle are now considering ways to rebuild Merrill Hall, which was firebombed at the University of Washington’s Center for Urban Horticulture last May, and will explain the pre-design phase and seek comments from the neighborhood and campus community Nov. 19.

Benefits advice

Marita Berg, King County coordinator for the Statewide Health Insurance Benefits Advisors (SHIBA) talks with John Salveson of Plant Operations at the Health Sciences session of the Benefits Fair, held Wednesday, Oct.

Briefly

Education’s role in shaping citizens examined in forum


Higher Education and Democratic Citizenship is the title of a forum to be held from 7 to 9 p.

Etc.

KID SAFETY: Seventeen low-income families whose children attend school in the UW’s Experimental Education Unit received free child and infant car seats, thanks to the University Police Department.

October 30, 2001

University of Washington to study use of medications by pregnant women

The University of Washington National Center of Excellence in Women’s Health is conducting new research into how drugs are handled in the body by pregnant women, a field which according to the U.S. Food and Drug Administration (FDA) deserves more attention. The FDA is providing $150,000 for the research to identify the doses that will provide the greatest benefit and the least risk for the mother and her baby. Dr. Mary Hebert, associate professor in the UW Department of Pharmacy, Dr. Tom Easterling, associate professor of obstetrics and gynecology, and Dr. Gail Anderson, associate professor in pharmacy and pharmaceuticals, will be conducting the study evaluating a high blood pressure medication commonly prescribed for pregnant women.